NCT04226508

Brief Summary

The "CHOICE!" study is an exercise program following the recommendation of the American College of Sports Science for cancer patients. The aims of the intervention are to test the safety and feasibility of a structured program, letting patients choose the modality of delivery. Secondary endpoints include exercise health-related skills and quality of life. The program considers the preferences of exercise of cancer survivors, giving the possibility to choose the exercise modality (autonomous, with a personal trainer or group class). This program will be tested in different cancer populations with different study designs based on different patients cohort (i.e., RCT or single-arm).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2019

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

December 20, 2019

Completed
24 days until next milestone

First Posted

Study publicly available on registry

January 13, 2020

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2024

Completed
Last Updated

November 14, 2023

Status Verified

November 1, 2023

Enrollment Period

3.8 years

First QC Date

December 20, 2019

Last Update Submit

November 13, 2023

Conditions

Outcome Measures

Primary Outcomes (5)

  • The number of participants with an adverse event

    Adverse events will categorize according to the Common Terminology Criteria for Adverse Events (version 5.0)

    Change from baseline to 12 weeks

  • The eligibility rate

    The number of patients considered eligible dividing the number of subjects who meet inclusion criteria

    At 12 weeks

  • The recruitment rate

    The number of patients randomized dividing the number of subjects considered eligible

    At 12 weeks

  • The adherence to exercise protocol

    Measured by the total number of exercise sessions attended

    At 12 weeks

  • The dropouts rate

    Defined as a participant who leaves the study for any reason prior to completing the 12-week (24 session) exercise program. All reasons for drop out will be reported.

    At 6 months

Secondary Outcomes (10)

  • Cardiorespiratory fitness

    Change from baseline cardiorespiratory fitness at 3 months

  • Upper limb muscle strength

    Change from baseline muscle strength at 3 months

  • Lower limb muscle strength

    Change from baseline muscle strength at 3 months

  • Upper limb flexibility

    Change from baseline flexibility at 3 months

  • Lower limb flexibility

    Change from baseline flexibility at 3 months

  • +5 more secondary outcomes

Study Arms (2)

Control

NO INTERVENTION

Physical exercise

EXPERIMENTAL
Other: Physical exercise

Interventions

The patients can choose between three modality of EX: 1. Autonomous supervised training : a personalized activity is proposed. People choosing this modality have a written material, in which all the exercise, the activity, the frequency, the duration, the intensity are specifically described and reported, to perform the training at home. A training diary and 7 meetings (face to face, or skype or other modality) are proposed for monitoring the intervention. 2. Personal training program: a personalized activity is proposed. Patients are followed individually in a gym contest by a qualified kinesiologist. 3. Group training program: the training is performed in a small group, supervised and monitored by a qualified kinesiologist. The instructor-user ratio is 1:4 - 1:8, depending on the functional conditions and the heterogeneity of the participants.

Physical exercise

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • a confirmed cancer diagnosis;
  • ≥ 8 weeks post-surgical procedure;
  • Medical clearance for participation provided by primary care physician or oncologist;
  • Informed consent signed;

You may not qualify if:

  • Age \< 18 years old;
  • Pregnancy;
  • Inability to ambulate;
  • Contraindication to participation in a regular physical activity program;
  • Inability to understand the instructions for PA and/or Mini Mental State index \<24;
  • Serious physical limitation and/or Karnofsky index \<50.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Italian League for Fight Cancer

Biella, Turin, 13900, Italy

Location

University of Verona

Verona, 37131, Italy

Location

Related Publications (1)

  • Avancini A, Borsati A, Baldo E, Ciurnelli C, Trestini I, Tregnago D, Belluomini L, Sposito M, Insolda J, Auriemma A, Fiorio E, Piacentini M, Schena F, Milella M, Pilotto S. A Feasibility Study Investigating an Exercise Program in Metastatic Cancer Based on the Patient-Preferred Delivery Mode. Oncologist. 2024 Jun 3;29(6):e828-e836. doi: 10.1093/oncolo/oyae002.

MeSH Terms

Interventions

Exercise

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Massimo Lanza

    Universita di Verona

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The CHOiCE includes different substudies, with different study designs, i.e., RCT, single arm.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Investigator

Study Record Dates

First Submitted

December 20, 2019

First Posted

January 13, 2020

Study Start

September 1, 2019

Primary Completion

June 30, 2023

Study Completion

July 30, 2024

Last Updated

November 14, 2023

Record last verified: 2023-11

Locations